Services

ParkCell's goal is to be able to provide cell transplantation based treatment services for patients suffering from Parkinson's Disease within 2-3 years. Potentially, this method could eventually present a cure for many PD patients.

Therefore, ParkCell is performing cutting edge pre-clinical and clinical research and development in the following areas:

1. Generation of cells for transplantation in Parkinson's disease
2. GMP grade cell culture protocols
3. Clinical transplantation methods and protocols
4. Melanocyte based biomarker discovery